Compare Illumina, Inc. (ILMN) vs ZIM Integrated Shipping Services Ltd (ZIM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs ZIM Integrated Shipping Services Ltd — how do they compare? Illumina, Inc. trades at $190.08 (market cap $27.94B), while ZIM Integrated Shipping Services Ltd trades at $24.73 (market cap $2.93B). The key difference: Illumina, Inc. is far larger — about 9.5× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | ZIM | |
|---|---|---|
Market Cap | $27.94B | $2.93B |
Sector | Health | Industrials |
52-Week High | $194.33 | $29.27 |
52-Week Low | $91.00 | $12.44 |
Enterprise Value | $29.33B | $6.78B |
Dividend Yield | — | 20.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
ZIM Integrated Shipping Services trades at $24.31, showing minimal daily movement with a 0.04% gain. The stock faces bearish technical signals and mixed analyst sentiment, with equal hold and sell ratings. Recent financials show declining revenue from $6.9B in 2025 to $6.3B projected for 2026, while net income dropped sharply from $479M to $98M. The company maintains strong cash flow from operations but faces challenges from regulatory setbacks in the Hapag-Lloyd acquisition and volatile freight rates.
ZIM presents a cautious outlook with significant downside risk to the $16.75 consensus price target. While valuation metrics appear attractive with P/S of 0.47 and P/B of 0.77, declining profitability and regulatory uncertainty offset potential upside. The key opportunity lies in resolution of merger negotiations, while risks include sustained freight rate pressure and ongoing cash burn trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About ZIM Integrated Shipping Services Ltd
ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →
